SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 229 filers reported holding SANGAMO THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.52 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $442,000 | -4.5% | 36,900 | 0.0% | 0.01% | 0.0% |
| Q1 2021 | $463,000 | -21.1% | 36,900 | -1.9% | 0.01% | -28.6% |
| Q4 2020 | $587,000 | +135.7% | 37,600 | +42.9% | 0.01% | +133.3% |
| Q3 2020 | $249,000 | -77.7% | 26,308 | -78.9% | 0.00% | -81.2% |
| Q2 2020 | $1,117,000 | +40.7% | 124,589 | 0.0% | 0.02% | +23.1% |
| Q1 2020 | $794,000 | -22.4% | 124,589 | 0.0% | 0.01% | +30.0% |
| Q4 2019 | $1,023,000 | -11.3% | 124,589 | -2.2% | 0.01% | -23.1% |
| Q3 2019 | $1,153,000 | -16.0% | 127,339 | 0.0% | 0.01% | -13.3% |
| Q2 2019 | $1,372,000 | +9.8% | 127,339 | -2.7% | 0.02% | +7.1% |
| Q1 2019 | $1,249,000 | -17.4% | 130,913 | -0.6% | 0.01% | -26.3% |
| Q4 2018 | $1,512,000 | -32.2% | 131,647 | 0.0% | 0.02% | -9.5% |
| Q3 2018 | $2,231,000 | +19.4% | 131,647 | 0.0% | 0.02% | +16.7% |
| Q2 2018 | $1,869,000 | -25.3% | 131,647 | +0.0% | 0.02% | -30.8% |
| Q1 2018 | $2,501,000 | +7.8% | 131,635 | -6.9% | 0.03% | +18.2% |
| Q4 2017 | $2,319,000 | +8.9% | 141,421 | -0.4% | 0.02% | +29.4% |
| Q3 2017 | $2,130,000 | +66.7% | 142,015 | -2.2% | 0.02% | +54.5% |
| Q2 2017 | $1,278,000 | +69.3% | 145,236 | 0.0% | 0.01% | +83.3% |
| Q1 2017 | $755,000 | +70.4% | 145,236 | 0.0% | 0.01% | +50.0% |
| Q4 2016 | $443,000 | -34.1% | 145,236 | 0.0% | 0.00% | -20.0% |
| Q3 2016 | $672,000 | -20.1% | 145,236 | 0.0% | 0.01% | -28.6% |
| Q2 2016 | $841,000 | -4.3% | 145,236 | 0.0% | 0.01% | -12.5% |
| Q1 2016 | $879,000 | -33.7% | 145,236 | 0.0% | 0.01% | -38.5% |
| Q4 2015 | $1,326,000 | +61.9% | 145,236 | 0.0% | 0.01% | +44.4% |
| Q3 2015 | $819,000 | -49.2% | 145,236 | 0.0% | 0.01% | -55.0% |
| Q2 2015 | $1,611,000 | -29.3% | 145,236 | 0.0% | 0.02% | -23.1% |
| Q1 2015 | $2,278,000 | +3.1% | 145,236 | 0.0% | 0.03% | +4.0% |
| Q4 2014 | $2,210,000 | – | 145,236 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Golden State Equity Partners | 154,360 | $897,000 | 0.45% |
| Rhenman & Partners Asset Management AB | 761,429 | $4,424,000 | 0.44% |
| Lombard Odier Asset Management (Switzerland) SA | 860,702 | $5,001,000 | 0.39% |
| WASATCH ADVISORS LP | 10,576,997 | $61,452,000 | 0.30% |
| Rokos Capital Management LLP | 977,663 | $5,861,000 | 0.27% |
| KLK CAPITAL MANAGEMENT LLC | 44,323 | $258,000 | 0.26% |
| Long Focus Capital Management, LLC | 340,000 | $1,975,000 | 0.25% |
| Vanguard Capital Wealth Advisors | 33,380 | $193,000 | 0.14% |
| Fort Sheridan Advisors LLC | 73,978 | $430,000 | 0.13% |
| Delphia (USA) Inc. | 20,983 | $122,000 | 0.09% |